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A model for the coregulation of smooth muscle actomyosin by caldesmon, calponin, 
tropomyosin, and the myosin regulatory light chain} 
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Burlingtoll, VT 05405-0063, U. S. A. 
Received December 3, 1993 
HAEBERLE, l.R .. and HEMRIC, M.E. 1994. A model for the eoregulation of smooth muscle actomyosin by caldesmon, 
calponin, tropomyosin, and the myosin regulatory light chain. Can. J. Physiol. Pharmacal. 72: 1400-1409. 
The purpose of these studies was to evaluate the effects of the actin-binding proteins tropomyosin. caldesmon, and calponin 
on the activation of smooth muscle actomyosin by phosphorylation of the regulatory light chain of myosin (LC 20). and to 
interpret these findings in the context of a two-state kinetic model for the cross-bridge cycle. An in vitro motility assay was 
used to broadly classify each regulatory protein according to whether it modulates the apparent on-rate for cross bridges 
(fapp) or the apparent off-rate (garp)' In addnion to measuring actin-filament velocity, a method was developed to measure 
relative changes in the force exerted on actin filaments under isometric conditions. Based primarily on the results of these 
motility studies, a qualitative model is proposed in which LC 20 phosphorylation, tropomyosin, and caldesmon all regulate 
fapp and calponin regulates gapp- The model predicts that the sensitivity of activation by LC 20 phosphorylation is determined 
by tropomyosin. caldesmon, and calponin, whereas unloaded shortening velocity is regulated primarily by calponin. 
Key words: smooth muscle, caldesmon, calponin, tropomyosin, motility assay. 
HAEBERLE, J.R .. et HEMRIC, M.E. 1994. A model for the coregulation of smooth muscle actomyosin by caldesmon, 
calponin, tropomyosin, and the myosin regulatory light chain. Can. 1. Physiol. Pharmacol. 72 : 1400-1409. 
Ces etudes ont eu pour but d'evaluer les effets des proteines de fixation de ractine, tropomyosine, caldesmone et calponine, 
sur I'activation de I'actomyosine du muscle Iisse par la phosphorylation de la LC20 , et d'interpreter ces resultats dans Ie 
contexte d'un modele cinetique 11 deux etats pour I'activite cyclique des ponts d'union. On a utilise un test de motilite in vitro 
pour differencier Ies protcines regulatrices selon qU'elles modulent I'ouverture apparente (fapp) ou la fermdure apparente 
(gapp) de l'activite des ponts d'union. En plus de mesurcr la vitesse des filaments d'actine, une methode a ete developpee 
pour mesurer les variations relatives de la force exercee par les filaments d'actine dans des conditions isomctriques. En se 
basant principalement sur les resultats de ces etudes de motilite, on propose un modele qualitatif dans lequella phosphoryla-
tion de la LC20 , la tropomyosine et la caldesmone regulent la iapp, alors que la calponine regule la gapp- Le modele predit 
que la sensibilite de I'activation de la phosphorylation de LC20 est determinee par la tropomyosine, la caldesmone et la 
calponine, alors que la vitesse de raccourcissement sans charge est regulee principalement par la calponine. 
Mots eNs: muscle Iisse, caldesmone, calponine. tropomyosine, test de motilite. 
[Traduit par la Redaction] 
Introduction 
In spite of the extensive pharmacologic literature on mam-
malian smooth muscles, the regulatory processes that govern 
the contractile proteins, actin and myosin, are not fully under-
stood (Somlyo and Somlyo 1994). It is well established that 
covalent phosphorylation of the regulatory light-chain subunit 
(LC2o) of smooth muscle myosin is an important and perhaps 
obligatory activation mechanism. With very few exceptions, 
smooth muscle contraction has been found to be associated 
with some elevation in the level of LC20 phosphorylation 
(Kamm and Stull 1985). And yet, almost two decades after the 
original observation that LC20 phosphorylation activates the 
actin-activated myosin ATPase activity of smooth muscle and 
nonmuscle myosins (Adelstein and Conti 1975), no unique 
relationship between Le20 phosphorylation and any single 
parameter of smooth muscle contraction has been found that 
is consistent for all smooth muscles. 
the apparent on-rate for crass bridges (fapp) or the apparent 
off-rate (gapp); and (iii) to develop a qualitative model that 
describes the interaction of these regulatory proteins in the 
regulation of cross-bridge cycling under both isometric and 
unloaded conditions. 
General considerations 
The regulation of smooth muscle contraction is somewhat 
unique compared with the regulation of striated muscles 
because of the so-called latch state3 that develops during sus-
tained contractions. The latch state is a highly economical state 
of force maintenance that appears to be the result of a reduced 
rate of cross-bridge dissociation from actin, similar to the 
catch state described in certain invertebrate smooth muscles. 
Cardiac and skeletal muscles can also convert to a slow-
cycling. high-economy contractile state. However, this involves 
the expression of specific myosin isoforms rather than dynamic 
The goals of the studies to be described here were (i) to 
evaluate the general hypothesis that the actin-binding proteins 
tropomyosin, caldesmon, and calponin modulate the activation 
of contraction by LC20 phosphorylation; (ii) to broadly clas-
sify each regulatory protein according to whether it modulates 
lThis paper was presented at the symposium entitled Smooth 
Muscle Contraction: Recent Advances, held August 23 - 27. 1993. at 
Minaki. Ont., and has undergone the Journal'; usual peer review. 
2 Author for correspondence. 
PnntcJ In CaJ\,ld<.l impnJllc dU C,Ul~llb 
3The latch-bridge model. proposed by Dillon et al. (I9R 1), sug-
gested that dephosphorylation of an attached cross bridge would 
decrease the rate of cross-bridge dissociation from actin. There now 
is considerable evidence that the cross-bridge dissociation rate is 
regulated in smooth muscle independent of any changes in LC 20 
phosphorylation, suggesting an alternate mode of regulation. The 
term "latch state" will be used here more generally to refer to the 
slow-cycling cross-bridge state observed in smooth muscle. without 
regard to the underlying regulatory mechanism. 
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ATP hy?rolysis .. A subsequent decrease in gapp would cause a 
further Increase In force, but this would be associated with a 
decrease in the rate of ATP hydrolysis back towards the rest-
ing level, or if both. Rapp and fapp decreas~d proportionately, 
force would be maintained by cross bndges cycling at a 
reduced rate. This is one possible model of how the latch state 
develops in smooth muscle. As a first step in the development 
of a model for the regulation of smooth muscle, several puta-
tive regulatory proteins were examined with regard to modula-
tion of lapp and (or) gapp' This was accomplished through the 
use of an in vitro motility assay with modifications that 
provided for the measurement of unloaded filament velocity as 
well as relative changes in the force exerted on actin filaments 
under isometric conditions. 
+~ 
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( e·;; ) f 
app 
CJCj!J 
J 
Relative Isometric Force = f,,, I(f,,, + g,pp) 
Isometric ATPase = (f,ppg,pp) I (f,pp+ g,pp) 
Unloaded Velocity = f (g,pp) 
Latch State = f (g",p) ? 
FIG. I. Two-state kinetic model of the cross-bridge cycle. 
regulation as is seen in smooth muscle. In spite of these differ-
ences between smooth and striated muscles, there is no a priori 
reason to presuppose that the latch state in smooth muscle can-
not be described by a simple two-state model of contraction in 
which both the on-rate and off-rate are regulated (Huxley 
1957; Hai et al. 1988). As illustrated in Fig. 1, cross bridges 
can be broadly grouped into one of two general states. During 
the relaxed state, cross bridges are at equilibrium between a 
diss~ciated sta.te ~nd a weak binding state, where cross-bridge 
blndmg to actin IS rapidly reversible and noncooperative (for 
review see Chalovich 1992). During contraction, cross 
bridges ~ycle through a strong-binding state, in which myosin 
cooperatively b~nds to actin with a 3000-fold higher affinity. 
Muscle sh?rtemng and (or) force development occur during 
the transitIOn from the weak-binding to the strong-binding 
state. 
In the Huxley (1957) model, the distribution of active cross 
bridges, under steady-state isometric conditions, is determined 
by the relative rates of cross-bridge attachment (j) and detach-
ment (R). Because both the on-rate and the off-rate for cross 
bridges are now known to involve a number of discrete inter-
mediate kinetic states, it is more appropriate to refer to an 
appa~~nt on-rate CJ:lpp) and an apparent off-rate (gapp) for the 
t~ansltJ~n of cross bndges between the non-force-producing 
(I.e., dissociated and weak binding) states and the force-
producing (i.e., strong binding) states (Brenner 1988). If the 
reverse rate constants ( -f and - g) are assumed to be negligi-
ble, then the level of isometric force is 
Normalized force = fapp 
fiPP + Rapp 
An increase in lapp or a decrease in gapp of equal magnitude 
would each produce the same increase in force. However, the 
resulting contractile states would be different because the 
overall rate of cross-bridge cycling and the rate elf A TP 
hydrolysis arc proportional to (r X o. )/( r + 0 ) J app '" "PI' J app ,~app 
(Brenner 1988). Consequently, force development associated 
with an increase in fapp would be associated with a propor-
tIOnal Increase In the rate of ATP hydrolysis, whereas force 
development associated with a decrease in g would be 
. d . ~ 
assoCIate With a proportional decrease in the rate of A TP 
hydrolysis. For example, assuming that in the relaxed state 
f"pp <{ garp' an increase in flpp would increase both force and 
In vitro motility assay 
Th~ form of motility assay that we have used for this pur-
pose IS based on the movement of actin filaments over a sur-
face of immobilized myosin similar to that described by Kron 
et al. (1991), with modifications to limit photochemical altera-
tions of proteins. In all of the studies described here smooth 
muscle myosin was thiophosphorylated to 2.0 mol P04/mol 
mYDsin and applied to a surface of nitrocellulose as mono-
meric myosin (300 mM KCl). Actin filaments were labeled 
with rhodamine - phalloidin and then bound to the myosin-
coated surface under rigor conditions. After washing out 
unbound actin, an ATP-containing motility buffer was added 
to initidte filament motility. Tropomyosin, caldesmon, and 
calponin were included in th, motility buffer. V clocity was 
measured at 30°C as described elsewhere, using a method that 
minimizes averaging errors for discontinuous filament motion 
(Haeberle et al. 1992). 
In agreement with the Huxley (1957) model, unloaded fila-
ment velocity is limited by the rate of cross-bridge detachment 
(Warshaw et al. 1991) and is independent of the number of 
cycling cross bridges (Haeberle 1994). Consequently, if care-
fulmeasures are taken to prevent filament loading in the motil-
ity assay, an increase in !app should have no effect on 
velocity, but should cause a proportional increase in both force 
and the rate of ATP hydrolysis. An increase in gapp' in con-
trast, should cause an increase in both the rate of ATP hydrol-
ysis and velocity, and a reduction in force. 4 
4The Huxley (1957) model contained two dissociation rate con-
stants for non isometric conditions: one for the dissociation of posi-
tively straIned working cross bridges and a second for negatively 
straIned cross bndges that had completed the work-producing portion 
of the cycle but which were still attached to actin. He argued that 
cross bndges become negatively strained prior to detachment during 
nontsometnc contraction because other positively strained cross 
bridges continue to translocate the actin filament. He also assumed 
that negative strain increased the rate of cross-bridge dissociation. 
With this modeL shortening velocity approached a limiting value 
when the total internal load due to negatively strained cross bridges 
equaled the total force generated by positively strained cross bridges. 
The rate of gapp IS bmlted by the rate of ADP release under both iso-
metric and isotonic conditions. Therefore, even though the values of 
gapp may be different under isometric and unloaded conditions. it is 
reasonable to assume that regulation of the rate of ADP release might 
change the dlssoClatlon rate under both conditions, and almost cer-
tainly would change both in the same direction. Since only directional 
changes In rate constants are being considered in the current model 
it will not be necessary to differentiate between g. for negativel~ 
d
... ~ J 
an pOSitively stramed cross hridges. 
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FIG, 2, Method for estimation of relative force (ForceNEM) using 
NEM-modified myosin. The minimum ratio of NEM-modifiedl 
unmodified myosin that prevented filament motion provided an index 
(ForceNEM) of the force generated 1}y unmodified cross bridg~s, 
Changes in ForceNEM with different experiment.al conditIOns pro-
vided a measure of relative changes in isometric force, ForceNEM 
value (FNEM) was independent of the myosin density on the cover 
slip (i.e., the concentration of NEM -myosin required to inhibit 
motility was linearly related to the concentration of unmodified myo-
sin applied), but was sensitive to changes in force production by 
different myosin isoforms and to changes in activation by phosphory-
lation and by actin-linked regulatory proteins, 
As a consequence of these considerations, it should be possi-
ble to determine if a regulatory factor is predominately affect-
ing f or g by measuring directional changes in isometric app app , . , , 
force, velocity, and actin-actIvated myosIn ATPase activIty, 
At this level of consideration, such measurements need only 
be accurate enough to resolve a significant positive or negative 
change, 
Mea-urement of unloaded velocity and isometric force:with 
the motility assay 
The motility assay can provide relatively accurate measure-
ments of changes in unloaded velocity and isometric force, but 
measurement of ATPase activity under the identical conditions 
that either force or velocity are measured is difficult because 
of the small amount of actin present. However, in almost all 
cases, measurements of force and velocity alone were suffi-
cient to determine the rate constant that was regulated. Force 
development by single actin filaments has been measured 
using calibrated microneedles (Ishijima et al. 1991; VanBuren 
et al. 1993) or a laser light trap (Saito et al. 1994). These 
methods have the advantage that they provide absolute mea-
sures of force, but they are technically very demanding and 
not well suited to making the large number of measurements 
necessary to compare several different proteins over a range 
of concentrations and phosphorylation levels. Fortunately, for 
our purposes absolute force measurements were not neces-
sary. With this in mind, a technically simpler method was 
developed to measure relative changes in the force exerted on 
actin filaments under isometric conditions (Fig. 2). N-Ethyl-
maleimide (NEM) modified skeletal muscle myosin was 
mixed with thiophosphorylated smooth muscle myosin to 
impose a mechanical load on the filaments. NEM modification 
of myosin produces a form of myosin that binds tightly to actin 
in the presence of Mg A TP, and impedes the motion of actin 
filaments with both skeletal and smooth muscle myosins 
(Warshaw et al. 1990). If a sufficient concentration of NEM -
myosin was mixed with thiophosphorylated myosin, filament 
motion ceased. Using a method of successive approximations, 
it was possible to determine the minimum amount of 
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FIG. 3, Effect of smooth muscle tropomyosin on filament motility. 
Different levels of myosin thiophosphorylation were achieved by 
mixing appropriate amounts of dephosphorylated myosin and myosin 
that had been thiophosphorylated with myosin light chain kinase to 
2.0 mol/mol. Values for ForceNEM (FNEM) were determined as 
described in Fig. 2 and by Haeberle (1994), The tropomyosin con-
centration was 1.8 /LM. 
NEM -myosin required to stop filament motion, and this 
provided an index of relative force (ForceNEM) (Haeberle 
1994), where 
F (mol NEM-modified myosin) orceNEM = 
(mol unmodified myosin) 
The ForceNEM value for thiophosphorylat~d smooth musc~e 
myosin was 3.4 times larger than for skeletal muscle myosin 
(Haeberle 1994) and compares favorably with the 3- to 4-fold 
force difference measured by VanBuren et al. (1993) using 
calibrated microneedles. 5 
While measurements of velocity are technically easier, they 
are not without pitfalls. Because of the steep velocity versus 
load relationship described by the force-velocity curve for 
muscle, it is important to minimize any stray mechanical 
loads, particularly when working at low myosin concentra-
tions or at low levels of activation. The absence of mechanical 
loading by factors other than myosin itself can be verified by 
showing that velocity is independent of changes in the density 
of myosin on .the cover slip. However, this docs not provide 
an adequate test for mechanical 10ading by photochemically 
modified forms of myosin (e.g., cross bridges that bind to 
actin but do not cycle), because the load would change in exact 
proportion to the number of force-producing cross bridges. 
Ideally, velocity should also be independent of changes In 
f and therefore demonstration of velocity independence app" . 
under conditions where iapp is regulated should proVide a bet-
ter test for mechanical loading. As will be discussed in later 
sections, our studies have shown that Le20 phosphorylation, 
caldesmon, and smooth muscle tropomyosin all regulate iapp' 
but not gapp' and have no effect on velocity when steps are 
taken to prevent photochemical modification. In contrast, all 
three altered velocity under more standard motility assay con-
ditions in which velocity was nonetheless independent of myo-
5Further details of the method and control expaiments demon-
strating the validity of this approach for measuring relative force 
changes are presented elsewhere (Haeberle 1994). 
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FIG. 4. Effect of intact caldesmon on filament binding and velocity. The inset panels show video images obtained by focusing the fluorescence 
microscope on the nitrocellulose-coated surface of the cover slip. In all the panels, the motility buffer contained 80 mM KCI, 1.6 I"M tropomyo-
sin and no added methylcellulose. Top panel, no added caldesmon; middle panel, 10 I"M dephosphorylated chicken gizzard caldesmon; bottom 
left panel, dcphosphorylated porcine aortic caldesmon; bottom right panel, porcine aortic caldesmon phosphorylated to 1.8 mol/mol with puri-
fied mitogen-activated protein kinase. Under these conditions filaments attached only in the presence of dephosphorylated caldesmon. The plot-
ted data summarize the effects of caldesmon on filament velocity in the presence of either I or 10 mM DTT. The motility buffer was identical 
with that used for the binding studies. Data are presented as means with 95% confidence intervals. Adapted from Haeberle et al. (1992). 
sin concentration. This clearly suggests that chemically 
modified myosin represents the major source of mechanical 
loading in the in vitro motility assay. 
In our experience, the inclusion of a robust chemical system 
to scavenge both oxygen and free radicals while maintaining 
reducing conditions within the flow cell was essential to estab-
lish unloaded conditions. We found that either 1 mg BSA 
(bovine serum albumin)!mL + 100 mM DTT (dithiothreitol) 
or 20 mg BSA/mL + 10 mM DTT in degassed motility buffer 
containing an oxygen scavenger system markedly reduced 
photobleaching and mechanical loading was less than about 
1 % of the ForceNEM produced by thiophosphorylated smooth 
muscle myosin (Haeberle et al. 1992).6 Photobleaching was 
"The addition of glucose, glucose oxidase, and catalase as an oxy-
gen scavenger system (Kishino and Yanagida 1988; Kron et al. 1991) 
and 1 mM DTT actually enhanced the oxidation of some soluble pro-
teins compared with I mM DTT alone, particularly if the solutions 
were not adequately degassed under vacuum (Haeberle et al. 1992). 
Presumably this was because the soluble proteins were present at 
J. 000 - 10 000 times the concentration of catalase, and would effec-
tively compete with catalase for the peroxide generated by glucose 
oxidase. 
further reduced by the use of image enhancement techniques 
(i.e., frame averaging and background subtraction) that 
allowed for visualization of the filaments with reduced illumi-
nation. 7 Under these conditions, filament motility can readily 
be monitored for more than 30 min with continuous illumi-
nation. 
Effect of LC20 phosphorylation on filament motility 
At lower ionic strength, there is a complex relationship 
between velocity and the extent of LC20 phosphorylation that 
is due to mechanical loading by unphosphorylated, attached, 
weak-binding cross bridges (Warshaw et al. 1990). At higher 
ionic strength (100 mM), there was no significant (analysis of 
variance, p < 0.05) effect of LC20 phosphorylation on veloc-
ity from 1.0 to 0.05 mol P04/moi LC20 in the presence of 
tropomyosin if very careful attention was paid to the elimina-
7 A 100-W mercury vapor lamp with a neutral density filter (5 % 
transmittance) in the illumination path. In general, the level of illumi-
nation was reduced until the filaments could just barely be visualized 
using a standard epit1uorescent microscope (Neofluar 100 x 11.30 NA, 
Carl Zeiss Inc., Thornwood, N.Y.) equipped with a SIT camcra 
(SIT-66, Dage-MTI Inc., Michigan City, Ind.). 
1..+0..+ CAN. 1. PHYSIOL. PHARM.".COL. VOL 72. 199-1 
Thin Filament 
_ Thick Filament 
1.0 f 
~ 0.8 
III 
c 
.. 
CJ 0.5 
C 
.. 
E 0.4 
.! f 
u: 
0.2 
0.0 0 
0 20 40 60 60 100 
[MBF] (pM) 
FIG. 5. Inhibition of caldesmon-dependent tethering by the N-terrninal 
(N-term) myosin-binding fragment (MBF) of caldesmon (CaD). The 
binding of skeletal muscle actin filaments to thiophosphorylated 
smooth muscle myosin immobilized on a nitrocellulose-coated cover 
slip (i.e., an in vitro motility assay). The concentrations oftropomyo-
sin and caldesmon were 1 and 0.4 11M, respectively. The N-terminal 
fragment of caldesmon was prepared by cleavage with 2-nitro-5-
thiocyanobenzoic acid. Filament density was normalized to the fila-
ment density measured in the absence of caldesmon. Filament bind-
ing was quantified using a computer program to determine the 
number and length of bound actin filaments. These values were multi-
plied together to determine a value for total bound actin. All data 
were normalized to the control value determined in the presence of 
0.4 11M intact caldesmon .• , binding in the presence of 0.4 11M 
intact caldesmon and different concentrations of N-terminal fragment 
(MBF); ,binding in the absence of both intact caldesmon and 
N-terminal fragment. The concentration of KCl in the motility buffer 
was 80 mM and that of tropomyosin was 1.6 11M. Methyl cellulose 
was not included. Values are presented as means with 95% confi-
dence intervals. Adapted from Hemric and Haeberle (1993). 
tion of all mechanical loading (unpublished results). When 
adequate measures were taken to limit chemical modification 
of contractile proteins, we determined that ForceNEM with 
fully thiophosphorylated myosin was 200-fold greater than 
ForceNEM with unphosphorylated myosin (unpublished 
results) and that ForceNEM is linearly related to the stoichiom-
etry of LC20 phosphorylation (Fig. 3). This suggested that 
LC20 phosphorylation only affects f1PP' in agreement with 
previous studies by Sellers (1985). These results are also con-
sistent with the argument that unloaded velocity is governed 
primarily by gapp' 
Effects of tropomyosin on filament motility 
We have not been able to demonstrate any significant effect 
of tropomyosin on velocity in the motility assay using thio-
phosphorylated smooth muscle myosin, when adequate mea-
sures are taken to prevent mechanical loading. Although we 
earlier observed that tropomyosin increased filament velocity 
by approximately 50 %, the measures we have since taken to 
eliminate photochemical modification have resulted in a 
progressive increase in filament velocity under all conditions 
and have eliminated the increase in velocity with the addition 
of tropomyosin. With our current protocol, we found that tropo-
myosin produced a modest increase in binding, and ForceNEM 
was increased by 67 % (Fig. 3) with no effect on velocity (see 
control values in Figs. 6 and 7). This indicated that tropomyo-
sin stimulates flPP but does not effect gapp' Presumably thc 
effect on velocity observed in earlier studies reflected the fact 
that the filaments were not completely unloaded, and conse-
quently, increasingjapp increased the force exerted on the fila-
ments without changing the load, leading to increased velocity 
as predicted by the force-velocity curve. 
The increased sensitivity of force activation by light-chain 
phosphorylation in the presence of tropomyosin suggests that 
smooth tropomyosin may function like skeletal tropomyosin to 
switch on the actin filament as described by Hill et al. (1981). 
These findings are consistent with previous studies by Somlyo 
et al. (1988) showing rigor-dependent force development in 
chemically permeabilized smooth muscle, as well as the report 
by Horiuchi and Chacko (1989) showing that tropomyosin 
enhances the cooperative switching on of actin by attached, 
high-affinity cross bridges. Vyas et al. (1992) have reported 
similar findings in chemically permeabilized smooth muscle 
fibers. However, they have interpreted their findings as evi-
dence for cooperative activation mediated through the myosin 
filament. 
Effects of caldesmon on filament motility 
While there was initially some controversy concerning the 
effects of caldesmon on actin-activated ATPase activity, 
studies from Chalovich's laboratory (Chalovich 1992) have 
shown that the C-terminal end of caldesmon competitively 
inhibits myosin binding to actin and consequently inhibits 
actin-activated ATP hydrolysis. The apparent increase in acto-
HMM (heavy meromyosin) binding that had previously been 
reported was shown to be due to the formation of an 
actin - caldesmon - HMM complex that tethers myosin to actin 
(Hemric and Chalovich 1990). We have verified both effects 
of caldesmon, using the motility assay. 
Caldesmon tethers actin filaments to myosin and thereby 
facilitates motility at a higher ionic strength (100 mM) in much 
the same way that methylcellulose prevents diffusion of 
unbound filaments away from the myosin surface (Fig. 4, 
insets). The ephanced binding could be shown to be specifi-
cally due to tethering by using a molar excess of purified 
N-terminal fragment to competitively block caldesmon-
dependent tethering (Fig. 5). This protocol demonstrated that 
the enhancement of binding was not due to an effect of caldes-
mon on the actomyosin interaction, because filament binding 
was decreased even though continued binding of both actin 
and myosin to caldesmon was assured by the presence of both 
intact caldesmon and the N-terminal fragment. Phosphoryla-
tion of the N-terminal fragment to 1.6 mol/mol by 
Ca2 + Icalmodulin-dependent protein kinase II (Hemric et a!. 
1993) prevented the inhibition of tethering, and phosphoryla-
tion of intact caldesmon to 1.8 mol/mol by mitogen-activated 
protein kinase8 prevented tethering (Fig. 4, inset). 
Kphosphorylated bovine aortic caldesmon (Adam and Hathaway 
\993) was provided by Dr. L.P. Adam (Indiana University School of 
Medicine). 
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FIG. 6. Effect of C-terminal, actin-binding fragment of caldesmon (Cald C-Term Frag) on filament binding and velocity. The inset panels 
show the inhibition of filament binding to the myosin surface under low salt conditions. The concentration of KCI in the motility buffer was 
25 mM and methylcellulose was not added. In the absence of fragment (left panel), filaments were bound tightly with little evidence of dissocia-
tion. The addition of 2.5 /lM fragment completely reversed filament binding to the myosin surface (right panel). To determine the effects of 
the fragment on filament velocity (plotted data), 0.5 % methylcellulose was included in the motility buffer to prevent diffusion of the filaments 
away from the myosin surface. Control studies have shown that methylcellulose alone has no effect on filament velocity. Adapted from Haeberle 
et al. (J 992). 
As shown in Fig. 6, a C-terminal fragment of caldesmon 
prevented binding of actin filaments to the myosin surface at 
low ionic strength (40 mM), but had no effect on filament 
velocity when 0.5 % methyJcellulose was added to the motility 
buffer to restrict diffusion of the filaments away from the sur-
face. 9 Likewise, we found that intact caldesmon had no effect 
on filament velocity (Fig. 4). Since there was no binding or 
motility at 100 mM ionic strength in the absence of caldesmon, 
9Because filament motion was very intermittent under these condi-
tions, estimation of the true filament velocity was hampered by the 
limited sampling rate of the video camera and the limitcd spatial reso-
lution of this imaging method (Work and Warshaw 1992). We have 
described clscwhcre (Haeberle et al. 1992) methods to increase the 
sampling frequency and, therefore, to minimize velocity measure-
ment errors under these conditions. Using these methods, velocity 
data were normally distributed (p < 0.05, XC test) witi, a SD that 
wa'; approximately 10% of the mean, In comparison, random sam-
pling at a slower rate (i.e., I ~O.I images/s) and calculation of veloc-
ity based on measured displacement between successive video images 
resulted in a lower mean velocity. a greater relative SD. and a veloc-
ity distribution that was highly skewed in the direction of lower 
velocities. 
any filaments that bound and moved at this higher ionic 
strength in the presence of caldesmon must have been moving 
while tethered via caldesmon. At caldesmon concentrations 
>0.2 JAM. filaments moved at 2.0-2.5 JAm/s when 10 mM 
DTT was included in the motility buffer. 10 These results ruled 
out the possibility that the caldesmon tether might be a load-
IOFigure 4 also illustrates the modest stimulation of velocity we 
found with intact caldesmon (2.5 11m/s) compared with control 
actin-tropomyosin (2.1 /lm/s). We have measured similar elevated 
velocities with low concentrations of calponin (2.6 /lm/s). This 
appears to be due to the elimination of velocity measurement errors 
under conditions where actin filament binding is enhanced and 
motion IS contlnuous rather than intermittent. Several observations 
support this conclusion. We found a similar but smaller increase in 
velocity with actin ~ tropomyosin filamenls when intermittent motion 
became more continuous with the addition of methylcellulose to the 
motility buffer at high salt (80 mM KCI). Allow salt (25 111M), where 
motion appears uninterrupted in the absence of methylcellulose. 
velocity was not increased in the presence of methylcellulose. And 
finally. vclocity was not increased in the presence of methylcellulose 
plus the C-terminal fragment of caldesmon where motion is intermit-
tent (2.1~2.2 I(m/s. see Fig. 6). 
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FIG. 8. Effects of tropomyosin (Tm), caldesmon (CaD), and cal po-
nin (CaP) on the regulation of ForceNEM by LC20 phosphorylation. 
Different levels of myosin thiophosphorylation were achieved by 
mixing appropriate amounts of dephosphorylated myosin and myosin 
that had been thiophosphorylated with myosin light chain kinase to 
2.0 mol/moL Values for ForceNEM (FNEM) were determined as 
described in Fig. 2 and by Haeberle (1994). The tropomyosin con-
centration was 1.8 fLM. The actin and actin + Tm curves were fit to 
the data shown in Fig. 3. All curves are least-squares fits to the Hill 
equation. 
bearing structure that could contribute to the latch state in smooth 
muscle. It appears more likely that caldesmon-dependent tether-
ing functions to promote the interaction of actin and myosin, 
as demonstrated in activated platelets (Hemric et a1. 1993). 
Preliminary findings have shown that caldesmon inhibits 
ForceNEM both)n the presence and absence of tropomyosin, 
with 50% inhibition at 10 ftM and complete inhibition at 40 ftM 
in the presence of tropomyosin. As shown in Fig. 8, caldes-
mon most potentially inhibits the enhancement of ForceNEM by 
tropomyosin at low levels of LC20 phosphorylation. If the 
25 % decrease in velocity that occurs at 10 ftM caldesmon 
(Fig. 4) is due to the loading effect of the caldesmon tether in 
the face of a 50% reduction of ForceNEM, and if the curvature 
of the force-velocity relationship is not affected, then the load 
imposed at this concentration of caldesmon could be no more 
than 10 -- 20 % of the maximum force measured in the presence 
of actin -tropomyosin. 
Taken together, these motility findings show that caldesmon 
alters lapp but has no effect on gapp' These findings are con-
troversial in that others have shown that caldesmon inhibits 
filament velocity in a similar motility assay (Shirinsky et a1. 
1992; Okagaki et a1. 1991). Ishikawa et a1. (1991) reported a 
stimulation of velocity at low concentrations followed by inhi-
bition at high concentrations. While it is not possible to be cer-
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tain why such differences were found, we have observed that 
intact caldesmon will inhibit velocity if sulfhydryl-dependent 
oligomerization is not prevented by the use of a robust free-
radical scavenger system as described above, both before and 
after caldesmon is added to the motility buffer (Fig. 4). 
Effects of calponin on filament motility 
We initially observed a very abrupt and complete inhibition 
of filament velocity at about 1 /LM calponin (Fig. 7, _), simi-
lar to previous reports by others (Shirinsky et al. 1992). The 
complete inhibition of motility appears to be the result of the 
excessively tight binding of actin to myosin in the presence of 
calponin (Haeberle et a!. 1994). Reducing the myosin concen-
tration to 100 /Lg/mL (D) resulted in normal motility at 
reduced velocity (0.7 /Lm/s) in the presence of calponin; veloc-
ity was insensitive to further decreases in myosin concentra-
tIon down to 10 /Lg/ml. 
Analysis of the effect of calponin on force generation 
demonstrated that there was a 3-fold increase in ForceNEM 
when calponin was present, and a dramatic increase in the sen-
sitivity of activation by LC20 phosphorylation (Fig. 8). The 
steep activation in the presence of calponin and tropomyosin 
is consistent with the idea that smooth muscle tropomyosin 
enhances the cooperative switching on of actin filaments by 
strong-binding cross bridges; in the presence of calponin, the 
number of strong-binding cross bridges would be increased for 
any level of LC20 phosphorylation. Taken together these find-
ings all suggest that calponin decreases gapp' but they cannot 
rule out a modest affect of calponin on lapp-
Model for the coregulation of force and velocity by 
LCzo phosphorylation, tropomyosin, caldesmon, and 
calponin 
Figure 9, summarizes the effects of the four putative regula-
tory proteins on actin filament motility and binding in the 
motility assay. These findings are the basis for the assignment 
of each regulatory protein to the regulation of lapp or garp' Of 
these four regulatory proteins, only calponin regulates gapp 
and unloaded velocity. Tropomyosin, LCzo phosphorylation, 
and caldesmon all appear to affect lapp exclusively and, there-
fore, must either activate contraction or modulate the sensitiv-
ity of activation. 
The qualitative model depicted in Fig. 10, generally outlines 
our current working model by which these four regulatory 
proteins could interact to regulate smooth muscle contraction. 
The left half of the figure corresponds to fully dephosphory-
lated (turned on) calponin, and the right half is phosphorylated 
(turned off) calponin. There is still considerable controversy 
about the phosphorylation state of calponin in situ; however, 
one of the clearest predictions of this model is that calponin 
must be regulated, either by phosphorylation or by some alter-
native second messenger. 
Another interesting aspect of the model is the prediction that 
both caldesmon and calponin can modulate the sensitivity of 
activation by LCzo phosphorylation. The model predicts, how-
ever, that caldesmon and calponin would have opposite effects 
Ol~ sensitivity. The model further predicts that only regulation 
of calponin would be associated with both a change in sensitiv-
Ity and a change in unloaded shortening velocity. Therefore, 
in hog carotid artery smooth muscle, where LC20 is tran-
siently phosphorylated and then dephosphorylated in parallel 
with a decline in unloaded shortening velocity while isometric 
FNEM Velocity Binding On Rate Off Rate 
Tm + 0 + + 0 
LC., 0 ? - 0 
CaD 0 +/- 0 
CaP + + ? 
FIG. 9. Summary of the effects of caldesmon (CaD), calponin 
(CaP), tropomyosin (Tm), and LC20 phosphorylation on filament 
binding, force, velocity, and lapp and gapp-
force is maintained or increases, the model predicts that cal po-
nin must be regulated (phosphorylated and dephosphorylated?) 
with a time course similar to that for LC20 phosphorylation 
and dephosphorylation. 
The model also predicts that constant or increasing isometric 
force in the face of declining or constant levels of LCzo phos-
phorylation, respectively, must be accompanied by either 
phosphorylation of caldesmon or activation (dephosphoryla-
tion?) of calponin. These two possibilities should be distin-
guishable on the basis of changes in actin-activated ATPase 
activity and unloaded shortening velocity. Phosphorylation of 
caldesmon would have no effect on shortening velocity, but 
would increase steady-state isometric A TPase activity, 
whereas activation of calponin would decrease both unloaded 
velocity and steady-state isometric ATPase activity. 
Summary 
Primarily on the basis of data derived from an in vitro motil-
ity assay, a qualitative model for the co regulation of cross-
bridge cycling by myosin light chain phosphorylation, caldes-
mon, calponin, and tropomyosin has been proposed. In this 
model, calponin is the sole regulator of the off-rate (gapp); 
caldesmon, tropomyosin, and LCzo phosphorylation all modu-
late the cross-bridge on-rate (lapp) and, consequently, govern 
steady-state force and A TP hydrolysis, with little effect on 
unloaded velocity. Since 0nly calponin has any effect on gapp' 
activation of the latch state in smooth muscle most likely 
involves regulation of calponin. In very general terms, this 
model is consistent with a large portion of the experimental 
data available, and there are few experimental reports that 
directly contradict the model. This latter point is more a 
reflection of the scarcity of phosphorylation data for caldes-
mon and calponin than it is support for the model. It should 
also be pointed out that this model does not, in its present 
form, exclude a more complex scheme resulting from a com-
bination of the present model and any of the alternative models 
that have been proposed, such as myosin-linked cooperativity 
(Vyas et a!. 1992), modulation of cross-bridge detachment by 
Mg ADP (Nishimura and van Breeman 1989), rigor-
dependent activation of actin (Somlyo et a!. 1988), or the 
latch-state model as described by Hai ancl Murphy (1988). 
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